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early life stress induced by limited 
nesting material produces metabolic 
resilience in response to a high-fat 
and high-sugar diet in male rats
Jayanthi Maniam , Christopher P. Antoniadis , Kristy W. Wang and Margaret J. Morris *
Department of Pharmacology, School of Medical Sciences, UNSW Australia, Sydney, NSW, Australia
Environmental conditions experienced in early life can profoundly influence long-term 
metabolic health, but the additive impact of poor nutrition is poorly understood. Here, 
we tested the hypothesis that early life stress (ELS) induced by limited nesting material 
(LN) combined with high-fat and high-sugar diet (HFHS) post-weaning would worsen 
diet-related metabolic risk. Sprague-Dawley male rats were exposed to LN, postnatal 
days 2–9, and at weaning (3  weeks), siblings were given unlimited access to chow 
or HFHS resulting in (Con-Chow, Con-HFHS, LN-Chow, and LN-HFHS, n =  11–15/
group). Glucose and insulin tolerance were tested and rats were killed at 13 weeks. 
LN rats weighed less at weaning but were not different to control at 13 weeks; HFHS 
diet led to similar increases in body weight. LN-chow rats had improved glucose and 
insulin tolerance relative to Con-Chow, whereas LN-HFHS improved insulin sensitivity 
versus Con-HFHS, associated with increased peroxisome proliferator-activated receptor 
gamma co-activator-1-alpha (Pgc-1α) mRNA in muscle. No effect of LN on plasma 
or liver triglycerides was observed, and hepatic gluconeogenic regulatory genes were 
unaltered. In summary, this study demonstrates that ELS induced by LN conferred some 
metabolic protection against insulin and/or glucose intolerance in a diet-dependent 
manner during adulthood.
Keywords: early life stress, limited nesting material, high-fat and high-sugar diet, insulin and glucose tolerance, 
liver and plasma triglycerides
introduction
Exposure to severe stress during early childhood can have an adverse impact on brain development 
and mental health outcomes during adulthood (1). The impact of early life stress (ELS) on metabolic 
disease risk, however, is less well explored. While there is strong evidence in the human linking 
childhood trauma with increased risk of metabolic diseases, such as insulin resistance, diabetes, and 
hyperlipidemia (2–4), it is unknown whether these adverse metabolic outcomes are a consequence 
of lifestyle choices. However, in animal studies, data regarding the impact of ELS on later metabolic 
health outcomes is controversial (5) with evidence for both improved (6, 7) and worsened (8–11) 
metabolic disease risk.
Evidence suggests that the modification of disease risk when an individual is exposed to ELS (5) 
depends on their subsequent lifestyle, but limited work has systematically examined the contribution 
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of these factors to the possible metabolic consequences of ELS 
(5). There is evidence in support of bad lifestyle choices following 
ELS, such as increased drug and food addiction (12). For exam-
ple, adult women who were abused as children were overweight, 
and this was strongly linked with food addiction (12). On the 
other hand, given the association between perceived stress with 
increased intake of high energy, palatable foods (13), the type of 
diet consumed during adulthood is strongly linked to metabolic 
profile later in life. There is also some evidence showing that a 
sub-optimal later environment (sedentary lifestyle, food insecu-
rity, a deficient diet or adult stress exposure) alters the risk for 
developing metabolic disorders (5). Given the difficulty in assess-
ing the direct contribution of lifestyle and diet to later outcomes 
in humans, animal models are useful as nutrition and activity can 
be more readily controlled. Further, use of animal models can 
provide insight into the underlying mechanisms of any metabolic 
consequences of ELS.
Poor nutrition, such as consuming a high-fat and high-sugar 
diet (HFHS), is a known risk factor for metabolic disorders, 
including hyperglycemia, insulin resistance, hyperlipidemia 
and increased inflammatory responses. Hence, understanding 
the consequences of the intake of such food following ELS is 
critical. Although prevention of ELS is ideal, unfortunately this 
is not feasible. Hence, it is important to explore other alternatives 
such as manipulating the adulthood environment (e.g, provid-
ing a positive environment) which may minimize metabolic 
disease risk and provide avenues to identify important targets for 
intervention. Studies using various models of ELS have examined 
the impact of later diet and reported different outcomes (5). For 
example, our lab demonstrated that in response to HFHS diet, 
male rats exposed to ELS by maternal separation in the first 
2 weeks after birth, had marked elevations in plasma insulin, and 
decreased total white adipose tissue (WAT) mass, independent 
of body weight compared to HFHS non-stressed controls when 
measured at 19 weeks of age (10, 11). In support, another model 
of ELS using maternal deprivation induced hyperinsulinemia and 
impairments in insulin sensitivity in early adulthood, measured 
through homeostasis model assessment-estimated insulin resist-
ance (HOMA-IR), in male offspring fed a high-fat diet (HFD) 
relative to HFD non-deprived controls (14). Recently, a new 
model of ELS that resembles the human condition of maternal 
neglect, using limited nesting material (LN), has been established 
(15). This model has been consistently shown to impair behavior 
and produce deficits in hypothalamic–pituitary–adrenal axis 
regulation of offspring; however, no work to date has examined 
the combined impact of LN and HFHS diet on metabolic function.
Different effects on metabolic profile were observed when rats 
exposed to ELS consumed a healthy diet post-weaning. For exam-
ple, when rats exposed to maternal separation were given normal 
chow, no adverse effect on the metabolic profile was seen (10, 11). 
Another study showed maternally separated rats had improved 
insulin sensitivity compared to control rats when maintained on 
healthy chow (6). In those rats exposed to maternal separation and 
given a diet deficient in n-3 polyunsaturated fatty acid (PUFA), 
insulin was almost doubled compared to siblings consuming a 
normal diet (8). Together these studies demonstrate that the type 
of diet consumed differentially affects metabolic profile during 
adulthood in those exposed to ELS. While the studies outlined 
above demonstrate an effect of ELS on insulin and glucose 
concentrations as a risk marker, they did not comprehensively 
examine glucose/insulin homeostasis through functional studies, 
except for one study on primates which demonstrated impaired 
insulin sensitivity as assessed by glucose clamp (9). Hence, it is 
not clear if ELS impairs insulin/glucose homeostasis, and how 
ELS interacts with later poor diet to impact insulin and glucose 
homeostasis.
In this study, we sought to examine whether a HFHS consumed 
later in life in those rats exposed to LN adversely affects glucose/
insulin homeostasis. Since muscle plays a key role in glucose 
and insulin uptake and utilization, an array of markers involved 
in insulin/glucose uptake and utilization were measured, includ-
ing insulin receptors and glucose transporters. Inflammation, 
insulin resistance, hepatic glucose production, and altered lipid 
metabolism are interlinked components of metabolic syndrome 
(16, 17). Previous work from our lab consistently demonstrated 
chronic consumption of HFHS diet-induced insulin resistance, 
lipid accumulation, and increased inflammation (17, 18). Hence, 
here we also examined whether ELS induced by LN alters the 
effects of diet on hepatic glucose production and lipid metabo-
lism during adulthood.
With the increase in obesity and the availability of cheap 
high energy food, it is likely that adverse early exposures and the 
consumption of such food may co-exist, hence understanding the 
consequences of choosing a HFHS diet following ELS is essential. 
To address this important issue, we explored how stress exposure 
during early development affects later metabolic profile. Using 
the LN paradigm, we first explored whether ELS produces any 
metabolic consequences in the face of a healthy diet, examining 
body composition, glucose/insulin handling, hepatic lipid accu-
mulation, and markers of hepatic glucose metabolism. Second, 
we sought to determine whether the metabolic complications 
induced by HFHS diet consumption were altered following 
LN exposure. Examining the interaction between ELS and diet 
provides an opportunity to determine whether the type of food 
consumed may increase vulnerability to, or resilience against diet 
induced metabolic deficits.
Materials and Methods
animals
All animal procedures were approved by the Animal Care and 
Ethics Committee of UNSW Australia. Male and Female Sprague-
Dawley rats (Animal Resource Centre, Perth, WA, Australia) were 
maintained in a temperature controlled (21–23°C) colony room on 
a 12-h light/dark cycle (lights on at 0700 h) with ad libitum access 
to standard laboratory chow and water. Mating was carried out in 
house with one male and four females in a cage. Once pregnancy 
was confirmed, pregnant dams were housed singly. When a litter 
was born before 09.00 h, the previous day was designated the day 
of birth [postnatal day 0 (PND 0)]. Litters comprising 9–15 pups 
were included and standardized to 12 pups/litter at PND 1 using 
pups from dams littering on the same day to minimize altera-
tions in maternal behavior and pup nutrition. Litters were housed 
with the dam in polypropylene cages (20 cm × 32 cm × 19 cm) 
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on wood shavings with a metal lid. On PND 2, two litters were 
assigned to either normal bedding (control) or LN. The cage envi-
ronment of LN dams was altered by fitting a metal bottom, raised 
slightly to allow collection of urine and droppings. Rats in the LN 
group were provided with a single piece of paper towel as bedding 
material. Both groups were left undisturbed between PND 2 and 
9, after which LN groups received normal bedding material until 
weaning. Number of male offspring per experimental group was 
between 11 and 15 depending on the measures.
Post-Weaning Diet
At PND 21, pups were weaned and housed 3–4 rats/cage. Male 
offspring were assigned to either standard laboratory chow 
(11  kJ/g, energy 12% fat, 21% protein, 65% carbohydrate, 
Gordon’s Specialty Stockfeeds, NSW, Australia) or standard labo-
ratory chow and palatable HFHS, SF03-020 (20 kJ/g, energy 43% 
fat, 17% protein, 40% sucrose supplied by Specialty Feeds, Glen 
Forrest, WA, Australia). Chow, water, and HFHS were available 
ad libitum. This generated four groups: Con-Chow; Con-HFHS; 
LN-Chow; and LN-HFHS, comprising n =  11–15/group. Rats 
were weighed at weaning and at regular intervals throughout the 
study. Food and liquid intake over 24 h was recorded at regular 
intervals by weighing food and bottles before presentation to the 
rats and again after 24 h. Energy intake per cage was measured 
and average intake was calculated based on the supplier’s infor-
mation mentioned above.
intraperitoneal glucose Tolerance Test
Pups underwent an intraperitoneal (i.p.) glucose tolerance test 
(IPGTT) at 10  weeks of age. Rats were fasted overnight and 
administered glucose (50%, 2 g/kg i.p., n = 8–9/group). For blood 
collection, a small transverse incision of the lateral tail vein was 
made using a sterile scalpel. Blood glucose concentrations were 
measured with a glucometer (Accu-Chek, Roche Diagnostics, 
Sydney, NSW, Australia) at baseline (0 min) and at 15, 30, 45, 60, 
90, and 120 min post-glucose injection. In addition, up to 300 μl of 
blood was collected at 0, 15, 30, 60, and 120 min post-glucose injec-
tion into ethylenediamine tetraacetic acid (EDTA)-coated tubes 
and maintained at 4°C then centrifuged (9677 × g, 23°C, 5 min) 
to separate plasma for measurement of insulin. The area under the 
curve (AUC) of the glucose concentrations was calculated for each 
rat for IPGTT and insulin concentrations during IPGTT.
intraperitoneal insulin Tolerance Test
Pups underwent an i.p. insulin tolerance test at 11 weeks of age. 
Rats were fasted for 6 h and a baseline glucose level was measured 
(Accu-Chek). The rats were administered insulin (Actrapid, 
Novo Nordisk; 100  IU/ml, 1  U/kg i.p., n =  8–9/group). Blood 
samples were obtained as above. Blood glucose concentrations 
were measured at 15, 30, 45, 90, and 120 min post-injection. The 
AUC of the glucose concentrations was calculated for each rat.
Terminal sample collection
At 13  weeks of age, after 16  h fasting, rats were anesthetized 
by ketamine/xylazine (Ketamine: 100  mg/ml Xylazine: 20  mg/
ml, dose: 100/15  mg/kg i.p.). Body weight was measured. Rats 
were decapitated and trunk blood was collected in heparinized 
tubes and centrifuged (9677 × g, 23°C, 8 min). The plasma was 
separated and stored at −20°C for subsequent determination of 
plasma insulin and triglycerides. Liver and left soleus muscle was 
dissected, weighed and snap frozen in liquid nitrogen and stored 
at −80°C for subsequent analysis. Left epididymal WAT, retrop-
eritoneal WAT, and visceral WAT were dissected and weighed.
hormone and lipid assays
Plasma insulin concentration was measured using a commercial 
ELISA kit (Millipore, Sydney, NSW, Australia). Prior to liver tria-
cylglycerol analysis, tissue (n = 12–15/group) was homogenized 
using a chloroform–methanol mixture as described elsewhere 
(19). Plasma and liver triacylglycerol content were determined 
using a colorimetric assay kit (Roche Diagnostics) with density 
measured on a BioRad iMark plate reader (BioRad, Sydney, NSW, 
Australia).
Quantitative real-Time Polymerase chain 
reaction
RNA was extracted using Tri-reagent (Sigma-Aldrich, Sydney, 
NSW, Australia) and treated with DNase I (Invitrogen, 
Melbourne, VIC, Australia) as previously described (10, 11) to 
remove any contaminating genomic DNA and stored at −80°C. 
RNA concentration was determined using a Biospec-nano 
spectrophotometer (Shimadzu, Sydney, NSW, Australia). Two 
micrograms of RNA was reverse transcribed to cDNA using 
Omniscript Reverse Transcription kit (Qiagen, Melbourne, 
VIC, Australia) and stored at −20°C. Quantitative real-time 
polymerase chain reaction (qRT-PCR) was performed on liver 
samples using Taqman probes (Applied Biosystems, Melbourne, 
VIC, Australia) for carbohydrate response element binding pro-
tein (Chrebp, Rn00580702_m1), glucose-6-phosphatase (G6pc, 
Rn00689876_m1), Glucocorticoid receptor (nuclear receptor 
subfamily 3, group C, member 1, Rn00565562_m1), hexose-
6-phosphate dehydrogenase (H6pd, Rn01519771_m1), Fatty 
acid synthase (FAS, Rn01463550_m1), 11-beta hydroxysteroid 
dehydrogenase 1 (11βHSD-1, Rn00567167_m1), cytoplasmic 
phosphoenolpyruvate carboxylase (Pepck, Rn01529014_m1), 
nuclear receptor subfamily 1, group H, member 3 (Nr1h3/LXRα, 
Rn00581185_m1), sterol regulatory element binding transcription 
factor 1(Srebp-1c, Rn01495769_m1), Sirtuin 1 (Sirt1, AJD1TRO), 
Sirtuin 3 (Sirt3, Rn01501410_m1), and tribbles homolog 3 (Trib3, 
Rn00595314_m1).
Five housekeepers were assessed and the stability of each was 
analyzed using Normfinder software. The two housekeepers 
with the highest stability value, TBP (TATA box binding protein, 
Rn01455646_m1) and beta-actin (Rn00667869_m1), were used 
as reference genes.
For soleus muscle gene expression related to glucose and 
insulin homeostasis, we performed qRT-PCR using micro 
fluid cards (Life Technologies), which were pre-customized 
with genes of interest including insulin-like growth factor 1 
(Igf1, Rn99999087), Insulin receptor (Insr, Rn00690703_m1), 
Insulin receptor 1 (Insr1, Rn02132493_s1), Insulin receptor 
2 (Insr2, Rn01482270_s1), Solute carrier family 2 (facilitated 
glucose transporter) membrane 4 (GLUT-4, Rn01471908), 
sterol regulatory element binding transcription factor 1c 
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(Srebp-1c, Rn01495769_m1), uncoupling protein 2 (UCP2, 
Rn01754856_m1) and Peroxisome proliferator-activated recep-
tor alpha (Pgc-1α, Rn00580241_m1). We used 1.5 μg of cDNA. 
One hundred microliters of cDNA/Mastermix (Advanced Fast 
Mastermix, Life Technologies) mixture was pipetted into the 
micro fluid cards; after centrifugation, the cards were sealed and 
qRT-PCR was performed. Housekeepers were assessed as above 
and the geometric mean of the two housekeepers with the highest 
stability value, Ywhaz (tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein) and Hprt1 (hypoxanthine 
phosphoribosyltransferase 1), was used. Analysis was performed 
using the ΔΔCT method and data expressed relative to a pooled 
calibrator sample.
statistical analysis
Data are presented as mean ± SEM. Bodyweight of pups over time 
was analyzed using one-way ANOVA with repeated measures, 
followed by post  hoc Fisher’s least significant difference (LSD) 
test. Differences in energy intake, organ weight, plasma hormone 
concentrations, and mRNA expression in liver and muscle tis-
sues were analyzed using two-way ANOVA followed by post hoc 
Fisher’s LSD. p < 0.05 was considered significant.
results
effects of ln exposure on Body Weight 
Trajectory
Figure 1A demonstrates the body weight trajectory from weaning 
(3 weeks of age) until 11 weeks in control and LN rats fed chow 
or HFHS diet. A significant interaction between age and treat-
ment was observed [F(24, 440) = 24.71, p < 0.0001]. While there 
were no differences in body weight across groups at weaning, LN 
male rats fed chow were significantly lighter versus control rats 
on chow from weeks 4 to 11 (p < 0.05, see Figure 1A). In those 
rats consuming HFHS, LN male rats were significantly lighter 
compared to control rats consuming the same diet from 7.5 weeks 
(p < 0.05) (see Figure 1A). As expected, HFHS diet consumption 
significantly increased body weight in control rats (Con-HFHS 
versus Con-Chow) from 4 weeks of age, while in LN male rats 
(LN-HFHS versus LN-Chow), an increase in body weight was 
observed from 5 weeks of age (p < 0.05, see Figure 1A).
effect of ln exposure on energy intake
When weekly energy intake is considered, there was no sig-
nificant interaction between age and treatment (LN and HFHS) 
(F <  1, see Figure  1B). When total weekly energy intake was 
considered (see Figure 1C), there was no significant interaction 
between LN and HFHS intake (F < 1) but a significant effect of 
HFHS intake was found [F(1,11) = 53.49, p < 0.0001]. HFHS-fed 
rats consumed more energy relative to chow-fed rats in LN and 
control rats (Figure 1C).
effects of ln exposure on glucose Tolerance
When blood glucose concentrations during the GTT test at 
10 weeks are considered, a significant interaction between time 
and treatment [F(18, 168) =  4.36, p <  0.0001] was observed. 
In those consuming chow, a lower glucose peak was observed 
at 15 and 30  min in LN rats relative to control rats (p <  0.05, 
Figure 2A). When AUC was considered, no significant interac-
tion was observed between LN exposure and diet (p > 0.05, see 
Figure 2A inset). Despite no significant difference being detected 
when considering the AUC during IPGTT across LN and control 
rats consuming chow (p  >  0.05, Figure  2A inset), the lower 
glucose peak exhibited by the LN rats at 15 and 30 min relative to 
control rats (p < 0.05, see Figure 2A) indicates that these rats have 
improved glucose tolerance in the initial 30 min after a glucose 
load.
However, in response to HFHS diet, LN-HFHS rats appeared 
to have similar glucose tolerance as Con-HFHS (see Figure 2A). 
Con-HFHS rats had higher blood glucose concentrations than 
their chow counterparts from 45 to 90 min post-glucose injec-
tion, while LN-HFHS rats had significantly higher glucose con-
centrations from 15 to 90 min post-glucose injection (p < 0.05, 
see Figure  2A). When overall AUC for glucose tolerance was 
considered, there was no significant interaction between LN 
exposure and HFHS intake (F < 1), but as expected, a significant 
effect of HFHS intake was present [F(1,28) = 22.67, p < 0.0001] 
in both LN and control rats (see Figure 2A inset).
effects of ln exposure on insulin secretion 
during iPgTT
Insulin secretion during the GTT was also measured, but there 
was no significant interaction between time and treatment (F < 1, 
see Figure 2B). When insulin AUC was calculated, there was also 
no significant interaction between LN exposure and HFHS intake 
(F < 1, Figure 2B inset). However, as expected, a significant main 
effect of HFHS intake on insulin secretion in response to glucose 
load [F(1,33) = 11.02, p < 0.0022] was observed (see Figure 2B 
inset).
effects of ln exposure on insulin Tolerance 
during iPgTT
Insulin tolerance tests were conducted at 11 weeks; in this test, a 
significant interaction between time and treatment was observed 
[F(18,180)  =  6.76, p  <  0.0001]. In those consuming chow, 
LN-Chow rats had improved insulin tolerance relative to Con-
Chow from 90 min onward (p < 0.05, Figure 2C).
However, in those consuming HFHS diet, glucose concentra-
tions post-insulin injection remained markedly higher in the 
Con-HFHS rats from 60  min post-injection relative to Con-
Chow rats (p <  0.05, see Figure  2C) but this effect of HFHS 
intake was absent in LN rats. Interestingly, glucose concentrations 
in LN-HFHS and LN-Chow rats were similar across all time 
points post-insulin injection (p > 0.05, see Figure 2C). Further, 
LN-HFHS rats had significantly lower glucose concentrations 
from 60 min post-insulin injection relative to Con-HFHS rats, 
which is suggestive of enhanced insulin sensitivity (p < 0.01, see 
Figure 2C).
When overall AUC for insulin tolerance was considered, 
as expected a significant effect of HFHS intake was observed 
[F(1,30) =  20.50, p <  0.0001] in both LN and control rats. In 
addition, interestingly, LN exposure appeared to improve glucose 
clearance in response to insulin injection in both chow- and 
HFHS-fed rats [F(1,30) = 16.31, p = 0.003, see Figure 2C inset]. 
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However, there was no significant interaction between LN 
 exposure and HFHS intake (F < 1).
effects of ln exposure on Offspring Body 
Weight, Organ Mass, and Plasma Measures
At weaning, body weights were significantly different across 
groups with reduced body weight in LN rats versus control rats 
[F(3,55) = 15.87, p < 0.0001]. At 13 weeks when rats were culled, 
two-way ANOVA analysis revealed that there was no significant 
interaction between LN exposure and HFHS intake on body 
weight (F < 1, see Table 1) but there was a significant main effect 
of LN exposure [F(1,53) = 79.26, p < 0.0001] and HFHS intake 
increased body weight [F(1,53) = 11.20, p = 0.002].
For muscle and total WAT mass, LN exposure had no effect on 
these parameters, independent of the diet consumed as evidenced 
by no significant interactions between LN exposure and HFHS 
intake on net mass, or following correction for body weight 
(F < 1). However, as expected HFHS diet increased WAT mass/
body weight versus chow-fed rats in both LN and control groups 
as evidenced by a main effect of diet on WAT mass/body weight 
[F(1,53) = 59.10, p < 0.0001, see Table 1]. Whereas for liver, LN 
exposure or the combination of HFHS intake had no effect on 
liver mass demonstrated by no significant interaction between 
LN exposure and HFHS intake, or main effect of LN exposure and 
HFHS intake on net or body weight adjusted liver mass (F < 1) 
(see Table 1).
Liver triglyceride content was measured as an index of 
hepatic lipid accumulation. There was no significant interac-
tion between LN exposure and HFHS intake (F < 1) on liver 
triglycerides but as expected a main effect of HFHS intake 
was present [F(1,56) = 67.95, p < 0.0001], where HFHS intake 
increased liver triglyceride four times versus chow counterparts 
in both LN and control groups (see Table 1). A similar pattern 
was observed in plasma triglyceride concentrations. HFHS 
intake increased plasma triglyceride three times in the control 
rats (Con-HFHS versus Con-Chow) and doubled it in the LN 
FigUre 1 | Body weight trajectory of male pups from weaning to 
11 weeks of age for chow (con-chow and ln-chow) and hFhs 
(con-hFhs and ln-hFhs) fed groups (a). Weekly energy intake  
(kJ/rat) for Con-Chow, LN-Chow, Con-HFHS and LN-HFHS, 
n = 3–4 cages/group (B). Total weekly energy intake for entire 
experimental window (c), with energy from chow shown in open and 
HFHS diet in closed bars. Results are expressed as mean ± SEM, 
n = 11–15/group; data were analyzed by repeated measures one-way 
ANOVA (a,B) and two-way ANOVA (c) followed by LSD. Definitions: 
Con-HFHS [control-HFHS; Con: normal bedding with mother; HFHS: 
post-weaning, postnatal day (PND) 21, chow, water, + HFHS] and 
LN-HFHS (LN-HFHS: LN: limited nesting material PND 2–9). #p < 0.05 
versus rats consuming HFHS (diet effect). *p < 0.05 versus control rats 
consuming the same diet (LN effect).
rats (LN-HFHS versus LN-Chow) [F(1,41) = 34.46, p < 0.0001, 
see Table 1].
Fasting blood glucose and plasma insulin concentrations were 
also measured at the end of the study. A significant interaction 
between LN exposure and HFHS intake was observed in plasma 
glucose concentrations [F(1,51) = 5.911, p = 0.019]. There was 
a main effect of diet [F(1,51) =  23.60, p <  0.0001] where the 
intake of HFHS diet significantly increased blood glucose con-
centrations in control rats by 39% (p < 0.0001, see Table 1), but 
this observation was absent in LN rats (p = 0.089, see Table 1). 
Thus, the glucose concentrations in LN-HFHS were significantly 
lower compared to Con-HFHS rats (p < 0.0001, see Table 1). On 
the other hand, for fasting insulin concentrations, there was no 
significant interaction between LN exposure and HFHS intake, 
but a main effect of HFHS intake [F(1,39) = 4.289, p = 0.0450] 
and LN exposure [F(1,39) = 7.490, p = 0.009] were observed (see 
Table 1).
effects of ln exposure on Mediators of insulin/
glucose and lipid Metabolism in Muscle
To examine the effect of LN exposure and HFHS intake on mark-
ers of insulin/glucose homeostasis, we measured several key 
mediators involved in insulin and glucose utilization and trans-
portation in muscle as outlined in Table 2. There were no signifi-
cant interactions between LN exposure and HFHS intake on all 
the insulin and glucose metabolism mediators measured, but as 
expected, there was a main effect of diet on insulin growth factor 
and insulin receptor mRNA expression in both LN and control 
groups [F(1,28) = 5.216, p = 0.03, see Table 2]. Insulin stimulates 
glucose transport in muscle by provoking the translocation of 
glucose transporters and glucose enters the muscle cell via facili-
tated diffusion through the GLUT-4 transporter, which translo-
cates to the plasma membrane. Here, GLUT-4 mRNA expression 
was measured in muscle; there was no significant interaction 
between LN exposure and HFHS intake, however as expected, a 
main effect of diet was found (p < 0.05, see Table 1). The role of 
FigUre 2 | glucose tolerance test at 10 weeks of age [(a), 2 g/kg of 
50% glucose] and area under curve (aUc) (inset). Insulin levels during 
glucose tolerance test (B) and insulin tolerance test (c) conducted at 
11 weeks. Results are expressed as mean ± SEM n = 8–10/group; data were 
analyzed by repeated measures two-way ANOVA (a–c) and two-way ANOVA 
for AUC [(a–c) insets] followed by LSD. Definitions: Con-HFHS [Control-HFHS; 
Con: normal bedding with mother; HFHS: post-weaning, postnatal day (PND) 
21, chow, water, +HFHS] and LN-HFHS (LN-HFHS: LN: limited nesting 
material PND 2–9). #p < 0.05 versus rats consuming chow (diet effect). 
*p < 0.05 versus control rats consuming chow (LN effect).
September 2015 | Volume 6 | Article 1386
Maniam et al. Metabolic consequences of early life stress
Frontiers in Endocrinology | www.frontiersin.org
UCP-2 in muscle is still the subject of debate. However, there is 
some evidence showing that UCP-2 is associated with obesity and 
hyperinsulinaemia. For example, muscle UCP-2 mRNA expres-
sion was reduced in obese subjects (20). UCP-2 mRNA expression 
in isolated muscle from the rat has been shown to be increased by 
insulin treatment in vitro (21). Here, LN exposure did not impact 
muscle UCP-2 mRNA expression but HFHS intake increased its 
expression across both groups as evidenced by a main effect of 
diet [F(1,28) = 5.20, p = 0.03]. Importantly, Pgc-1α, an oxidative 
metabolism marker that plays a key role in mitochondrial bio-
genesis and insulin metabolism, was significantly affected by LN 
exposure and HFHS intake with significant interaction between 
these two factors [F(1,26) = 8.919, p = 0.006]. Further, a main 
effect of HFHS intake [F(1,26) = 13.62, p = 0.001] and a main 
effect of LN exposure was found [F(1,26) =  4.478, p =  0.044]. 
While HFHS intake had no effect on muscle Pgc-1α mRNA 
expression in control rats, interestingly in LN rats, HFHS intake 
dramatically increased Pgc-1α mRNA expression levels relative 
to chow counterparts (p =  0.0002). Moreover, Pgc-1α mRNA 
expression in LN-HFHS rats was 110% more than the Con-HFHS 
rats (p =  0.0014). Since chronic HFHS intake is a known risk 
factor for lipid accumulation in muscle, Srebp-1c was measured; 
TaBle 1 | effects of limited nesting material (ln) and high-fat and high-sugar (hFhs) intake on offspring phenotype at 13 weeks.
con ln con-hFhs ln-hFhs significance
interaction Diet ln
BW weaning (g) 30.3 ± 0.7 24.7 ± 0.9* 32.7 ± 1.1 26.0 ± 1.1* – – –
BW terminal (g) 357.9 ± 7.8 330.1 ± 8.6 478.1 ± 17.3 425.0 ± 13.9 ns p < 0.0001 p = 0.002
Muscle (g) 2.26 ± 0.19 2.06 ± 0.12 3.08 ± 0.06 2.73 ± 0.10 ns p < 0.0001 p = 0.041
Muscle (%BW) 0.63 ± 0.04 0.64 ± 0.01 0.65 ± 0.02 0.65 ± 0.02 ns ns ns
WAT (g) 3.42 ± 0.28 3.00 ± 0.44 12.43 ± 1.73 9.29 ± 1.03 ns p < 0.0001 p = 0.067
WAT (%BW) 0.96 ± 0.07 0.91 ± 0.14 2.52 ± 0.30 2.14 ± 0.19 ns p < 0.0001 ns
Liver (%BW) 3.09 ± 0.09 3.11 ± 0.11 3.35 ± 0.09 3.19 ± 0.07 ns ns ns
Liver triglycerides (mg/g) 1.46 ± 0.20 1.23 ± 0.087 5.53 ± 0.79 5.41 ± 0.79 ns p < 0.0001 ns
Plasma
Glucose (mmol/l) 7.59 ± 0.52 6.77 ± 0.48 11.93 ± 0.86# 8.22 ± 0.52*# p = 0.019 p < 0.0001 p = 0.02
Insulin (ng/ml) 0.53 ± 0.03 0.46 ± 0.02 0.63 ± 0.06 0.50 ± 0.03 ns p = 0.045 p = 0.009
Triglycerides (mg/ml) 0.57 ± 0.07 0.53 ± 0.07 1.58 ± 0.22 1.11 ± 0.18 ns p < 0.001 ns
Apart from weaning body weight and food intake, the data are terminal, after 16 h fast.
Results are expressed as mean ± SEM; data were analyzed by one-way ANOVA for body weight at weaning and two-way ANOVA for other parameters followed by LSD, 
n = 3–4 cages/group for food intake and n = 11–15/group for other measures.
Abbreviations/definitions: BW, body weight; WAT, total white adipose tissue, includes epididymal, retroperitoneal, and visceral WAT, muscle weight is the sum of soleus and 
gastrocnemius; Con-HFHS [control-HFHS; Con: normal bedding with mother; HFHS: post-weaning, postnatal day (PND) 21, chow, water + HFHS] and LN-HFHS (LN-HFHS: LN: 
limited nesting material PND 2–9). 
Con-HFHS and LN-HFHS groups for body weight at weaning are pre-diet groups. Post hoc analysis performed when significant interaction (p < 0.05) between diet and LN present.
#p < 0.05 versus rats consuming chow (diet effect).
*p < 0.05 versus control rats consuming the same diet (LN effect).
TaBle 2 | effects of limited nesting material (ln) exposure and high-fat and high-sugar (hFhs) intake on insulin/glucose and lipid metabolism 
mediators in muscle.
con ln con-hFhs ln-hFhs significance
interaction Diet ln
Insulin growth factor 1.11 ± 0.17 1.03 ± 0.16 1.73 ± 0.23 1.93 ± 0.18 ns p < 0.01 ns
Insulin receptor 1.29 ± 0.30 1.29 ± 0.11 1.89 ± 0.28 2.13 ± 0.45 ns p = 0.03 ns
Insulin receptor 1 1.08 ± 0.15 1.22 ± 0.22 1.13 ± 0.17 0.96 ± 0.15 ns ns ns
Insulin receptor 2 1.43 ± 0.44 1.20 ± 0.23 2.00 ± 0.38 1.10 ± 0.17 ns ns ns
Glucose transporter-4 1.16 ± 0.21 1.28 ± 0.16 1.71 ± 0.16 2.18 ± 0.45 ns p = 0.013 ns
Srebp-1c 1.09 ± 0.17 1.71 ± 0.18 2.11 ± 0.36 1.97 ± 0.35 ns p = 0.04 ns
Pgc-1α 1.12 ± 0.21 0.87 ± 0.17 1.32 ± 0.17 2.78 ± 0.57*# p = 0.006 p = 0.001 p = 0.044
UCP2 1.11 ± 0.17 1.19 ± 0.16 1.81 ± 0.30 1.60 ± 0.28 ns p = 0.03 ns
Results are expressed as mean ± SEM; data were analyzed by two-way ANOVA followed by LSD, n = 6–9/group. The data are terminal, after 16 h fast. Post hoc analysis was 
performed when significant interaction between diet and LN was present. mRNA expression was assessed using microfluid card platform (Life Technologies).
Abbreviations/definitions: Srebp-1c, sterol regulatory element binding transcription factor; Pgc-1α, peroxisome proliferator-activated receptor alpha; UCP2, uncoupling protein 2; 
Con-HFHS [control-HFHS; Con: normal bedding with mother; HFHS: post-weaning, postnatal day (PND) 21, chow, water, + HFHS] and LN-HFHS (LN-HFHS: LN: limited nesting 
material PND 2–9).
Post hoc analysis performed when significant interaction (p < 0.05) between diet and LN present.
#p < 0.05 versus rats consuming chow (diet effect).
*p < 0.05 versus control rats consuming the same diet (LN effect).
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however, no significant interaction between LN exposure and 
HFHS intake was observed. As expected, a significant main effect 
of diet was observed where increases in Srebp-1c were observed 
in Con-HFHS versus Con-Chow [F(1,28) = 4.776, p = 0.037, see 
Table 2], but this appears to be absent in the LN group.
effects of ln exposure on hepatic 
gluconeogenic and lipid Metabolism genes
To examine the effects of LN exposure and HFHS intake on hepatic 
glucose synthesis, the expression of several key gluconeogenic 
genes including Sirtuin 1, Sirtuin 3, Pepck, G6pc, and Trib3 
were measured as outlined in Table 3. There were no significant 
interactions between LN exposure and HFHS intake in all the 
parameters measured. However, as expected a significant HFHS 
effect was observed in Pepck mRNA expression (p = 0.001, see 
Table 3). Interestingly, this is the first time an effect of diet on 
liver Trib3 mRNA expression was observed where HFHS intake 
reduced Trib3 mRNA expression in both LN and control groups 
(p = 0.02, see Table 3). No effect of LN exposure on Trib3 mRNA 
expression was observed.
TaBle 3 | effects of limited nesting material (ln) exposure and high-fat and high-sugar (hFhs) intake on mediators of hepatic glucose production and 
lipid metabolism.
con ln con-hFhs ln-hFhs significance
interaction Diet ln
gluconeogenic genes
Sirtuin 1 1.05 ± 0.08 1.15 ± 0.06 1.04 ± 0.012 0.92 ± 0.06 ns ns ns
Sirtuin 3 1.06 ± 0.09 1.02 ± 0.07 0.83 ± 0.07 1.06 ± 0.14 ns ns ns
Trib3 1.06 ± 0.09 1.11 ± 0.16 0.80 ± 0.15 0.74 ± 0.11 ns p = 0.02 ns
Pepck 1.06 ± 0.10 1.30 ± 0.11 0.75 ± 0.09 0.80 ± 0.11 ns p = 0.001 ns
G6pc 1.09 ± 0.17 1.35 ± 0.20 1.02 ± 0.16 1.06 ± 0.16 ns ns ns
lipogenic genes
Srebp-1c 1.11 ± 0.20 0.80 ± 0.11 2.43 ± 0.40 2.55 ± 0.50 ns p < 0.0001 ns
FAS 1.08 ± 0.11 1.33 ± 0.15 0.95 ± 0.13 1.54 ± 0.15  ns ns p = 0.004 
Chrebp 0.99 ± 0.07 1.10 ± 0.03 0.96 ± 0.07 1.27 ± 0.09 ns ns ns
glucocorticoid Metabolism genes
11βHSD-1 1.02 ± 0.06 1.06 ± 0.07 0.64 ± 0.07 0.56 ± 0.05 ns <0.0001 ns
GR 0.99 ± 0.07 0.98 ± 0.05 1.23 ± 0.10 1.19 ± 0.07 ns p = 0.028 ns
Lxr-α 1.03 ± 0.07 0.96 ± 0.07 0.86 ± 0.07 0.94 ± 0.07 ns ns ns
H6PD 1.06 ± 0.09 1.03 ± 0.08 0.83 ± 0.06 1.08 ± 0.14 ns ns ns
Results are expressed as mean ± SEM; data were analyzed by two-way ANOVA followed by LSD, n = 11–15/group. mRNA expression was assessed using regular RT-PCR using 
Taqman pre-optimized primers. The data are terminal, after 16 h fast.
Abbreviations/definitions: Con-HFHS [control-HFHS; Con: normal bedding with mother; HFHS: post-weaning, postnatal day (PND) 21, chow, water, + HFHS] and LN-HFHS 
(LN-HFHS: LN: limited nesting material PND 2-9). H6PD, hexose-6-phosphate dehydrogenase; Trib3, tribbles homolog 3; Pepck, cytoplasmic phosphoenolpyruvate carboxylase; 
Chrebp, carbohydrate response element binding protein, G6pc, glucose-6-phosphatase; Srebp-1c, sterol regulatory element binding transcription factor; FAS, fatty acid synthase; 
LXRα, nuclear receptor subfamily 1, group H, member 3; 11βHSD-1, 11-beta hydroxysteroid dehydrogenase 1; GR, nuclear receptor subfamily 3, group C, member 1.
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Given tissue glucocorticoid metabolism mediators, including 
(11βHSD-1 and glucocorticoid receptor), also regulate gluconeo-
genic enzymes, including Pepck and G6Pc, the gene expression 
of 11βHSD-1, and glucocorticoid receptor were measured. We 
observed no significant interaction between LN exposure and 
HFHS intake on 11βHSD-1 and glucocorticoid receptor mRNA 
expression (F <  1); however, a main effect of HFHS diet was 
observed in 11βHSD-1 [F(1,41) = 43.28, p < 0.0001] and gluco-
corticoid receptor [F(1,46) = 5.148, p = 0.028] mRNA expression.
We also measured FAS and Srebp-1c mRNA, which regulates 
genes related to lipid synthesis, and as expected, a significant diet 
effect was observed in Srebp-1c mRNA expression in the liver 
across both LN and control groups (F(1,54) = 22.32, p < 0.0001, 
see Table 3) with no significant interaction between LN exposure 
and HFHS intake (see Table 3). For FAS expression, while there 
was no significant interaction between LN exposure and diet, 
interestingly, a main effect of LN exposure [F(1,48)  =  9.116, 
p  =  0.0041] was observed, where LN exposure appeared to 
increase FAS mRNA expression in HFHS relative to Con-HFHS 
rats. Chrebp induces lipogenic gene expression, and here, Chrebp 
mRNA expression was not affected by LN exposure or HFHS diet 
(F < 1).
Discussion
This study expands the understanding of the impact of chronic 
consumption of HFHS from weaning on glucose and insulin 
homeostasis, lipid accumulation, and associated mediators of 
these systems in muscle and liver in male rats exposed to ELS 
during the first week of life. LN exposure differentially affected 
glucose and insulin tolerance during adulthood, which was 
dependent on the diet the animals consumed. Specifically, 
LN-chow rats had improved glucose and insulin tolerance rela-
tive to control rats given chow and LN-HFHS rats were glucose 
intolerant, but exhibited improved insulin sensitivity versus Con-
HFHS rats. Moreover, LN-HFHS rats had lower fasting glucose 
versus Con-HFHS rats. Other metabolic parameters, including 
liver triglycerides and their associated gene expression in the 
liver, were not affected by LN exposure in both diets. Hepatic 
gluconeogenic regulatory genes were also not altered.
ln rats were lighter at Weaning but 
experienced “catch Up” growth in chow- and 
hFhs-Fed groups
In our hands, ELS induced by LN resulted in lighter rats relative to 
control unstressed rats at weaning; however, these rats appeared 
to experience catch-up growth where LN rats had similar body 
weight as the control rats consuming the same diet at 13 weeks 
of age. This was in line with similar energy intake across both 
the LN and Con groups. Another study using the LN model also 
reported catch-up growth as rats matured (22). However, pups 
exposed to another model of ELS, maternal separation, showed 
no effect on body weight compared to control rats consuming 
regular diet at weaning (10). The LN model results in pups 
receiving fragmented care (15) versus maternally separated pups 
receiving enhanced arched back nursing (10). The differences in 
care provided by the dams across these two models may explain 
the differential impact of the ELS model on body weight at 
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weaning. In addition, the fact that LN pups weighed less than 
the control rats at weaning likely suggests that these LN rats were 
also nutritionally challenged due to the nature of care provided 
by LN dams to their pups.
ln exposure Modified glucose and insulin 
Tolerance in a Diet-Dependent Manner
In terms of glucose and insulin handling, LN exposure differen-
tially affected glucose and insulin tolerance in a diet-dependent 
manner. In those consuming chow, improved glucose clearance 
in the initial 30 min of GTT in LN rats versus control rats seems 
to be linked to enhanced insulin sensitivity as demonstrated by 
insulin tolerance test data. This data highlights that LN exposure 
produced some beneficial effects in maintaining glucose homeo-
stasis in response to a regular diet. However, another study in 
primates using variable foraging demand as a model of ELS 
demonstrated that offspring that went on to consume chow had 
developed insulin resistance at 4 months of age, as measured by 
insulin clamps (9). The reasons for the differences in observa-
tions are likely related to differences in species, experimental 
model, and even the age of assessment. Whether the improved 
glucose tolerance and insulin sensitivity observed in LN-chow 
rats remains as these animals age is unknown.
We have consistently showed that chronic consumption of 
HFHS impaired glucose and insulin tolerance (23, 24). Here, 
glucose tolerance in response to HFHS diet was similar between 
LN and Con rats and, as expected, HFHS intake delayed glucose 
clearance in control rats relative to their chow counterparts. 
However, it is important to highlight that while the HFHS diet 
effects on glucose tolerance in Con rats appeared from 45 min 
post-glucose injection, for LN rats, the diet effect was apparently 
earlier at 15 min post-glucose injection. This suggests that LN rats 
consuming HFHS diet responded differently to a glucose chal-
lenge versus unstressed Con rats. Despite being glucose intoler-
ant, LN-HFHS rats failed to show impaired insulin tolerance as 
observed in Con-HFHS rats. In addition, in the face of HFHS diet, 
LN rats exhibited enhanced insulin sensitivity relative to controls. 
The lower insulin response to glucose challenge seen during the 
second phase of GTT, albeit statistically non-significant, was 
also in line with the improved insulin sensitivity observed in 
LN-HFHS versus Con-HFHS rats.
These findings are the first demonstration showing ELS in the 
form of LN enhanced insulin sensitivity in response to HFHS 
intake. One of the few studies performed examined the impact of 
HFHS intake on fasting insulin concentrations and insulin sensi-
tivity index following maternal separation – and no effect of HFHS 
diet was observed in maternally separated rats versus control rats 
fed HFHS diet (6). Taken together, these data further suggest that 
ELS provides some protection against adverse effects induced by 
HFHS on insulin homeostasis. The underlying mechanism as 
to why LN exposure improved insulin sensitivity and lowered 
insulin response in response to HFHS is unclear. There are other 
physiological stressors, such as dietary restriction, that are known 
to improve insulin sensitivity across many species (25, 26). The 
fact that LN rats were lighter at weaning means that this model 
had some features that coincided with mild dietary restriction. 
In models of dietary restriction, improvement in mitochondrial 
biogenesis was demonstrated through increases in muscle Pgc-1α 
(27) and UCP2 (28) mRNA expression, and this mechanism was 
proposed to play a role in the improved insulin sensitivity (29, 
30). The likely contribution of changes in the expression of these 
genes will be discussed below.
It is also important to note that in our hands, while changes 
in glucose and insulin tolerance were apparent, the overall AUC 
for these tests was not significantly altered. Thus, future work 
should use a more robust test for insulin sensitivity, such as an 
insulin clamp, to validate the differential effects of diet on insulin 
sensitivity following LN exposure observed in this study. The 
mechanism(s) underlying this altered response to diet in LN rats 
are unclear. To understand the potential mechanisms mediating 
the effects of LN on insulin/glucose homeostasis, several key 
mediators of insulin and glucose metabolism were measured in 
muscle. As expected, we observed a diet effect on insulin growth 
factor, insulin receptor, and GLUT-4, but LN exposure did not dif-
ferentially affect these markers. In muscle cells, elevated levels of 
Pgc-1α stimulated insulin-sensitizing effects via the upregulation 
of selected genes involved in fatty acid β-oxidation, glucose trans-
port, and oxidative phosphorylation (31, 32). Further, increases in 
muscle Pgc-1α mRNA has recently been shown to be associated 
with increased insulin sensitivity in both animals and humans (33, 
34). In addition, skeletal muscle specific Pgc-1α KO mice exhibited 
glucose intolerance pointing to the importance of Pgc-1α in glu-
cose regulation in skeletal muscle (25). The upregulation of Pgc-1α 
mRNA expression we observed in LN-HFHS rats relative to Con-
HFHS rats may be associated with the enhanced insulin sensitivity 
observed in LN-HFHS rats; however, the direct contribution of 
Pgc-1α in the improvement of insulin sensitivity needs to be 
systematically validated in future work using knock-out models.
ln exposure had no effects on Plasma and 
hepatic lipid Profile
In this study, even though our findings were consistent with 
previous work showing HFHS intake significantly increased 
plasma and liver triglyceride concentrations, contrary to our 
hypothesis, LN exposure did not modify lipid levels in chow- 
or HFHS-fed rats. To the best of our knowledge, there is no 
evidence, thus far, on the impact of ELS on hepatic lipid accu-
mulation in either human or animal studies. It was interesting to 
note that despite no significant interaction between LN exposure 
and diet, a main effect of LN exposure on lipogenic gene (FAS) 
expression in the HFHS-fed rats where LN rats given HFHS diet 
had increased FAS mRNA expression. Hence, we examined if LN 
exposure modifies expression of Chrebp and Srebp-1c mRNA, 
which regulates the induction of lipogenic genes, such as FAS, in 
response to glucose and insulin, respectively (35). In this study, 
hepatic Chrebp and Srebp-1c were not affected by LN exposure in 
either chow- or HFHS-fed rats. We also examined liver histology 
for any signs of lipid accumulation following LN exposure in 
HFHS-fed rats. Histological investigation of the liver revealed 
a greater accumulation of lipid vacuoles within hepatocytes in 
those consuming HFHS across LN and control rats. However, 
LN exposure had no impact on lipid accumulation in rats given 
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chow or HFHS diet (data not shown).This study provides the 
first evidence that ELS in the form of LN produced no additive 
effect on the HFHS diet induced increases in plasma and hepatic 
lipid accumulation.
ln exposure had no effects on hepatic glucose 
gene expression
In response to physiological challenges, such as fasting, the 
liver maintains glucose homeostasis. Hence, long-term fasting 
initiates gluconeogenesis (36) by increasing the expression of key 
gluconeogenic enzymes Pepck and G6pc (37). Here, we observed 
no differences in the expression of Pepck and G6pc mRNA in the 
liver across LN and control rats when rats were fasted for 16 h. 
However, we found Pepck mRNA was reduced by HFHS diet. 
Hepatic Trib3 expression is reported to be highly expressed in 
animal models of diabetes (38), hence promoting hyperglycemia 
presumably by increasing glucose production in the liver. Trib3 
mRNA expression in liver biopsy samples of obese subjects was 
strongly correlated with Pepck mRNA (39). However, here, HFHS 
intake halved the expression of Trib3 mRNA in LN and control 
rats as evidenced by a main effect of diet and this was in line with 
reduction of Pepck mRNA by the diet.
Hepatic 11βHSD-1 also plays a role in regulating key hepatic 
gluconeogenic enzymes, including Pepck and G6Pc through the 
amplification of glucocorticoid receptor-mediated tissue gluco-
corticoid action, and is crucially dependent on H6PD to generate 
NADPH (40, 41). Increased activity of 11βHSD-1 was observed 
in non-fasted rats versus fasted rats (40) and in the same study, 
11βHSD-1 activity, H6PD, and glucocorticoid receptor mRNA 
expression were increased by glucose in a dose-dependent man-
ner (40). However, here, under conditions of 16 h fasting, HFHS 
intake almost halved 11βHSD-1 mRNA in the liver across both 
LN and control rats and increased glucocorticoid receptor mRNA 
expression. These observations are in line with no changes in the 
expression of glucose synthesis genes (Pepck and G6pc) after 16 h. 
Further, this study has produced the first evidence that hepatic 
gluconeogenic gene expression is not influenced by LN exposure 
in chow- and HFHS-fed rats.
conclusion
Overall, this study demonstrates that ELS induced by LN 
conferred metabolic protection against insulin and/or glucose 
tolerance during adulthood. Particularly in those consuming 
chow and previously exposed to LN, signs of improved glucose 
clearance were observed in the first 30  min post-glucose chal-
lenge and enhanced insulin sensitivity in the last 30 min following 
insulin challenge. In those consuming a HFHS, LN did not impact 
glucose tolerance but modestly enhanced insulin sensitivity. This 
was associated with increased Pgc-1α expression in the muscle. 
We hypothesize that the altered response to LN exposure accord-
ing to the diet consumed is related to developmental programing 
of glucose/insulin metabolism in peripheral tissues that enabled 
LN rats to demonstrate enhanced insulin sensitivity even when 
challenged with HFHS. However, whether this metabolic profile 
can be maintained as these animals age is yet to be explored. 
Further, LN exposure produced no effects on lipid accumulation 
in plasma or liver, and the relevant lipid markers were also not 
altered, regardless of diet. Moreover, hepatic glucose metabolism 
genes were also not altered by LN exposure in both diets. Overall, 
the results support the notion of greater metabolic “resilience” in 
LN rats, as previously discussed in Maniam et al. 2014 (5).
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